Chemtreat, Inc.

Chemtreat, Inc., a subsidiary of Veralto Corporation, manufactures industrial water treatment chemicals and provides related services to federal agencies as a prime contractor (99% of recent awards) under GSA schedules and indefinite delivery vehicles, competing on full and open terms without set-aside designations. Chemtreat is a for-profit corporate entity headquartered in Glen Allen, Virginia, classified under NAICS 311812 (All Other Miscellaneous Chemical Product and Preparation Manufacturing) and PSC 6840 (Chemicals), with a 761-award footprint spanning four decades of federal contracting and a combined potential value of $73.6 million.

Customer concentration reflects a bifurcated profile anchored by a single large prime but distributed across numerous smaller accounts. The National Institutes of Health Construction division represents 48% of combined potential value across 33 delivery orders ($35.2 million), with work centered on recurring and non-recurring water treatment maintenance, chemical consumables (layup chemicals, salt pellets, biocides), system upgrades, and specialty installations at NIH facilities in Bethesda, Maryland and Glen Allen, Virginia. The remaining 52% spreads across the Department of Veterans Affairs, the United States Marine Corps, the Department of Justice Bureau of Prisons network (Federal Correctional Complex Florence, Federal Correctional Institution Milan, United States Penitentiary Hazleton, and Federal Correctional Complex Allenwood), the Department of Defense, and 59 other civilian and defense agencies. Award volume by count diverges sharply from value: the Marine Corps leads in frequency (42 awards, $759 thousand), but those orders are individually small; DOJ Bureau of Prisons facilities collectively place 93 small delivery orders but total only $1.9 million.

Chemtreat's vehicle position centers on two primary vehicles: the GSA Multiple Award Schedule (88 task orders, $20.7 million combined potential value) and a $9.66 million single-award indefinite delivery contract with NIH Construction running through September 2027 (29 task orders, $10.5 million). Chemtreat also holds a Federal Supply Schedule GS10F7720A position carrying 322 task orders valued at $5.4 million. The NIH IDC, awarded October 1, 2022 through full and open competition, underwrites the bulk of Chemtreat's highest-dollar work, including a $1.93 million option year two exercise (September 2024), a $470 thousand upgrade-controller delivery order (July 2024), a $412 thousand maintenance and support call (June 2025), and recurring deliveries of salt pellets and layup chemicals ranging from $17 thousand to $276 thousand per task order. GSA MAS work consists of smaller tactical orders for cooling tower chemicals, chiller chemicals, and water treatment consumables to correctional facilities and the Washington Headquarters Service.

Activity trajectory shows modest recent growth: 9 awards in 2022 to 20 in 2025, with 9 awards recorded year-to-date in 2026 (as of June 23). A recompete exposure of $2.2 million is concentrated in the next twenty-four months across nine awards, a relatively low cliff relative to the portfolio size. The vendor's subcontract footprint is minimal (1% of all awards, 5 named subs): Chemtreat subcontracts to Professional Contract Services, Inc. for base operations and facility maintenance (water treatment system maintenance and operating plan development), to Valiant Government Services LLC for building renovation and corrective maintenance at Fort Detrick ($35.9 thousand chemical water treatment sub), to Bering Global Solutions LLC for naval support facility operations (open-loop cooling system treatment at Naval Support Activity Hampton Roads), and to M.C. Dean, Inc. for the TIM III San Antonio Exercise (recurring water treatment services).

Chemtreat's concrete capability portfolio focuses on industrial water treatment chemicals and services delivered through three primary channels: GSA MAS delivery orders for commodity chemicals (oxidizing and non-oxidizing biocides, corrosion and deposition inhibitors, cooling tower cleaners, boiler treatments, layup chemicals); the NIH IDC for comprehensive water system support including chemical treatments, system maintenance, laboratory testing, specialized equipment installation, and piping modifications; and small purchase orders to correctional facilities and military installations for routine chemical replenishment. Representative NIH work includes a May 2026 $288 thousand order for water treatment maintenance, chemical pumps, and lab testing at Brinklow, Maryland; a May 2026 $181 thousand task for relocation of chemical delivery lines at the NIH Bethesda campus; and a February 2024 $153.5 thousand delivery order for labor, supervision, and materials to replace tubing with PVC piping and perform cleaning, layup, and passivation work at Bethesda. GSA MAS examples include routine $10 thousand to $40 thousand delivery orders to correctional facilities for chiller chemicals, cooling tower chemicals, and closed-loop water system treatments, and a $143.7 thousand 2023 definitive contract with the Washington Headquarters Service for oxidizing biocide supply to the Raven Rock Mountain Complex. Recent activity also includes a $1.32 million GSA MAS delivery order (April 2025) for boiler, chiller, closed-loop, and incinerator wastewater chemical treatment services at the National Bio and Agro-Defense Facility in Manhattan, Kansas, and a $1.027 million delivery order (July 2025) from the Plains Area USDA for reverse osmosis and water softener systems at the same facility.

Chemtreat operates as a subsidiary of Veralto Corporation, a for-profit technology and life sciences conglomerate. The parent company structure supplies no additional capability framing beyond water treatment solutions. GSA labor offerings are minimal—one active schedule category (Field Service Engineer at $151.13 per hour, bachelor's degree required, 10 years' experience, no clearance) — reflecting the vendor's product and consumables posture rather than labor-intensive services. The vendor's federal work carries no SBA designations and does not compete under set-asides.